NOVEL CHIRAL ALIPHATIC–AROMATIC DIAMINE
857
(S)-2-((R)-1-(4-Chlorophenyl)-2-nitroethyl)cyclohex- 23.40 min, [a]D25 5 –15.0 (c 5 0.21, CH2Cl2); 1H NMR
anone (18b).32 White solid, 92% yield; syn/anti > 99:1, (300 MHz, CDCl3) d (ppm): 7.22–6.92 (m, 4H), 4.93 (dd, J
ee (major) 5 99%, determined by HPLC analysis (Chir- 5 4.5, 12.5 Hz, 1H), 4.60 (dd, J 5 10.1, 12.4 Hz, 1H), 3.77
alpak AS-H, i-PrOH/hexane 5 10/90, flow rate 1.0 mL/ (td, J 5 4.5, 9.9 Hz, 1H), 2.73–2.58 (m, 1H), 2.53–2.30 (m,
min, k 5 210.5 nm, tr (minor) 5 19.37 min, tr (major) 5 2H), 2.15–2.03 (m, 1H), 1.83–1.52 (m, 4H), 1.31–1.14 (m,
22.11 min; [a]D25 5 –14.3 (c 5 0.64, CH2Cl2); 1H NMR 1H).
(300 MHz, CDCl3) d (ppm): 7.30 (d, J 5 8.4 Hz, 2H), 7.12
(S)-2-((R)-2-Nitro-1-p-tolylethyl)cyclohexanone
(d, J 5 8.4 Hz, 2H), 4.93 (dd, J 5 4.5, 12.6 Hz, 1H), 4.61
(18h).14 White solid, 99% yield; syn/anti 5 99:1, ee
(major) 5 91%, determined by HPLC analysis (Chiralpak
AS-H, i-PrOH/hexane 5 20/80, flow rate 10 mL/min, k 5
(dd, J 5 10.2, 12.3 Hz, 1H), 3.82–3.70 (m, 1H), 2.72–2.58
(m, 1H), 2.53–2.30 (m, 2H), 2.16–2.01 (m, 1H), 1.86–1.58
(m, 4H), 1.31–1.14 (m, 1H).
211.7 nm, tr (minor) 5 7.26 min, tr (major) 5 10.76 min,
(S)-2-((R)-1-(2-Chlorophenyl)-2-nitroethyl)cyclohex- [a]D25 5 –15.0 (c 5 0.21, CH2Cl2); 1H NMR (300 MHz,
anone (18c).14 White solid, 99% yield; syn/anti > 99:1, ee CDCl3) d (ppm): 7.12 (d, J 5 7.9 Hz, 2H), 7.04 (d, J 5 8.0
(major) 5 90%, determined by HPLC analysis (Chiralpak Hz, 2H), 4.92 (dd, J 5 4.5, 12.3 Hz, 1H), 4.61 (dd, J 5 9.9,
AS-H, i-PrOH/hexane 5 20/80, flow rate 10 mL/min, k 5 12.3 Hz, 1H), 3.78–3.65 (m, 1H), 2.74–2.59 (m, 1H), 2.53–
210.5 nm, tr (minor) 5 8.66 min, tr (major) 5 11.14 min; 2.35 (m, 2H), 2.31 (s, 3H), 2.14–2.02 (m, 1H), 1.83–1.61
[a]D25 5 –36.7 (c 5 1.04, CH2Cl2); 1H NMR (300 MHz, (m, 4H), 1.31–1.15 (m, 1H).
CDCl3) d (ppm): 7.43–7.14 (m, 4H), 4.89 (d, J 5 6.5 Hz,
2H), 4.36–4.21 (m, 1H), 2.99–2.83 (m, 1H), 2.53–2.30
(m, 2H), 2.16–2.02 (m, 1H), 1.86–1.49 (m, 4H), 1.41–1.23
(m, 1H ).
(S)-2-((R)-1-(4-Methoxyphenyl)-2-nitroethyl)cyclo-
hexanone (18i).32 White solid, 93% yield; syn/anti 5
97:3, ee (major) 5 92%, determined by HPLC analysis
(Chiralpak AD-H, i-PrOH/hexane 5 20/80, flow rate 05
(S)-2-((R)-1-(2,4-Dichlorophenyl)-2-nitroethyl)cy- mL/min, k 5 223.4 nm, tr (minor) 5 17.04 min, tr (major)
clohexanone (18d).51 White solid, 93% yield; syn/anti > 5 20.11 min, [a]D25 5 –11.2 (c 5 0.61, CH2Cl2); H NMR
1
99:1, ee (major) > 99%, determined by HPLC analysis (300 MHz, CDCl3) d (ppm): 7.08 (d, J 5 8.6 Hz, 2H), 6.85
(Chiralpak AD-H, i-PrOH/hexane 5 10/90, flow rate 10 (d, J 5 8.6 Hz, 2H), 4.91 (dd, J 5 4.6, 12.3 Hz, 1H), 4.59
mL/min, k 5 210.5 nm, tr (minor) 5 8.78 min, tr (major) (dd, J 5 10.0, 12.2 Hz, 1H), 3.78 (s, 3H), 3.76–3.65 (m,
5 11.47 min; [a]D25 5 241.1 (c 5 0.35, CH2Cl2); H NMR 1H), 2.71–2.58 (m, 1H), 2.53–2.31 (m, 2H), 2.15–2.02 (m,
1
(300 MHz, CDCl3) d (ppm): 7.41 (d, J 5 1.9 Hz, 1H), 7.26– 1H), 1.85–1.58 (m, 4H), 1.31–1.14 (m, 2H).
7.14 (m, 2H), 4.88 (d, J 5 6.9 Hz, 2H), 4.25 (dt, J 5 7.0, 9.4
(S)-2-((R)-1-(2-Methoxyphenyl)-2-nitroethyl)cyclo-
Hz, 1H), 2.94–2.80 (m, 1H), 2.53–2.31 (m, 2H), 2.18–2.06
(m, 1H), 1.88–1.52 (m, 4H), 1.42–1.23 (m, 1H).
hexanone (18j).17 White solid, 99% yield; syn/anti 5
97:3, ee (major) > 99%, determined by HPLC analysis
(S)-2-((R)-1-(4-Bromophenyl)-2-nitroethyl)cyclohexa- (Chiralpak AS–H, i-PrOH/hexane 5 15/85, flow rate 10
none (18e).32 White solid, 90% yield; syn/anti 5 98:2, ee mL/min, k 5 211.7 nm, tr (minor) 5 9.99 min, tr (major)
(major) 5 92%, determined by HPLC analysis (Chiralpak 5 11.14 min, [a]D25 5 –25.4 (c 5 0.45, CH2Cl2); H NMR
1
AS-H, i-PrOH/hexane 5 20/80, flow rate 05 mL/min, k 5 (300 MHz, CDCl3) d (ppm): 7.23 (d, J 5 6.4 Hz, 1H), 7.09
210.5 nm, tr (minor) 5 19.96 min, tr (major) 5 30.32 min; (d, J 5 6.5 Hz, 1H), 6.89 (t, J 5 7.7 Hz, 2H), 4.91–4.76 (m,
[a]D25 5 –12.7 (c 5 1.05, CH2Cl2); 1H NMR (300 MHz, 2H), 4.02–3.90 (m, 1H), 3.84 (s, 3H), 3.06–2.90 (m, 1H),
CDCl3) d (ppm): 7.46 (d, J 5 8.3 Hz, 2H), 7.06 (d, J 5 8.3 2.54–2.30 (m, 2H), 2.15–2.00 (m, 1H), 1.81–1.54 (m, 4H),
Hz, 2H), 4.93 (dd, J 5 4.5, 12.6 Hz, 1H), 4.60 (dd, J 5 10.0, 1.30–1.11 (m, 1H).
12.5 Hz, 1H), 3.75 (td, J 5 4.5, 9.9 Hz, 1H), 2.71–2.59 (m,
1H), 2.53–2.31 (m, 2H), 2.15–2.04 (m, 1H), 1.87–1.58 (m,
4H), 1.31–1.14 (m, 1H).
(S)-2-((R)-2-Nitro-1-(4-nitrophenyl)-ethyl)cyclohex-
anone (18k).14 Brown oil, 96% yield; syn/anti 5 88:12, ee
(major) 5 84%, determined by HPLC analysis (Chiralpak
(S)-2-((R)-1-(2-Bromophenyl)-2-nitroethyl)cyclohexa- AD-H, i-PrOH/hexane 5 10/90, flow rate 10 mL/min, k 5
none (18f).16 White solid, 90% yield; syn/anti > 99:1, ee 210.5 nm, tr (minor) 5 14.34 min, tr (major) 5 29.67 min,
(major) 5 92%, determined by HPLC analysis (Chiralpak [a]D25 5 –22.1 (c 5 0.46, CH2Cl2); 1H NMR (300 MHz,
AS-H, i-PrOH/hexane 5 10/90, flow rate 08 mL/min, k 5 CDCl3) d (ppm): 8.20 (d, J 5 8.6 Hz, 2H), 7.40 (d, J 5 8.6
212.0 nm, tr (minor) 5 17.49 min, tr (major) 5 22.80 min;. Hz, 2H), 5.00 (dd, J 5 4.4, 13.0 Hz, 1H), 4.70 (dd, J 5 10.1,
[a]D25 5 –37.4 (c 5 1.01, CH2Cl2); 1H NMR (300 MHz, 12.9 Hz, 1H), 4.00–3.88 (m, 1H), 2.81–2.64 (m, 1H), 2.55–
CDCl3) d (ppm): 7.58 (d, J 5 8.0 Hz, 1H), 7.35–7.09 (m, 2.31 (m, 2H), 2.19–2.06 (m, 1H), 1.76–1.55 (m, 3H), 1.38–
3H), 5.01–4.82 (m, 2H), 4.38–4.24 (m, 1H), 3.01–2.81 (m, 1.15 (m, 2H).
1H), 2.54–2.32 (m, 2H), 2.16–2.04 (m, 1H), 1.88–1.61 (m,
(S)-2-((R)-1-(Naphthalen-2-yl)-2-nitroethyl)cyclohex-
4H), 1.45–1.31 (m, 1H).
anone (18l).32 White solid, 88% yield; syn/anti 5 99:1, ee
(S)-2-((R)-1-(4-Fluorophenyl)-2-nitroethyl)cyclohex- (major) 5 90%, determined by HPLC analysis (Chiralpak
anone (18g).32 White solid, 92% yield; syn/anti 5 98:2, AS-H, i-PrOH/hexane 5 50/50, flow rate 07 mL/min, k 5
ee (major) 5 90%, determined by HPLC analysis (Chir- 223.4 nm, tr (minor) 5 9.11 min, tr (major) 5 14.94 min,
alpak AS-H, i-PrOH/hexane 5 10/90, flow rate 1.0 mL/ [a]D25 5 221.1 (c 5 0.43, CH2Cl2); H NMR (300 MHz,
1
min, k 5 210.5 nm, tr (minor) 5 15.93 min, tr (major) 5 CDCl3) d (ppm): 7.86 – 7.74 (m, 3H), 7.63 (s, 1H), 7.53–
Chirality DOI 10.1002/chir